Emily Waltz. Show Affiliations »
Abstract
Mesh: See more » Biotechnology/economicsBiotechnology/legislation & jurisprudenceBiotechnology/trendsCanadaDrug Industry/economicsDrug Industry/legislation & jurisprudenceDrug Industry/trendsEuropeFilgrastimGranulocyte Colony-Stimulating Factor/pharmacologyHumansRecombinant ProteinsUnited StatesUnited States Food and Drug Administration
Substances: See more » Recombinant ProteinsGranulocyte Colony-Stimulating FactorFilgrastim
Year: 2008 PMID: 18779793 DOI: 10.1038/nbt0908-962
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908